Ebymect
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ebymect, covering 2026-03-13 to 2026-06-05. Get the full timeline:
Most recent: EMA Authorised: Ebymect (dapagliflozin propanediol monohydrate;metformin hydrochloride) — AstraZeneca AB